Abstract
After small-cell lung cancer (SCLC) and thymoma, ovarian cancer probably has the highest incidence of paraneoplastic syndromes. Unlike SCLC and thymoma, in which multiple paraneoplastic syndromes associated with multiple paraneoplastic antibodies are common, most patients with ovarian and other gynecologic cancers suffer from one of two paraneoplastic syndromes: paraneoplastic cerebellar degeneration (PCD) associated with the anti-Yo antibody (Chapters 5 and 12) or paraneoplastic encephalomyelitis associated with ovarian teratoma (usually benign) and the anti-NMDAR antibody (Chapters 4 and 13). Other paraneoplastic syndromes sometimes occur, but they are decidedly rare. Paraneoplastic syndromes associated with breast cancer are far more diverse and can be associated with several antibodies. Most patients with testicular cancer suffer from a single paraneoplastic syndrome, encephalomyelitis affecting brainstem and hypothalamus with anti-Ma2 antibodies (chapters 4 and 11).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
